ATE340569T1 - Verwendung eines neuen mittels zur verhütung von infektionen - Google Patents

Verwendung eines neuen mittels zur verhütung von infektionen

Info

Publication number
ATE340569T1
ATE340569T1 AT03739394T AT03739394T ATE340569T1 AT E340569 T1 ATE340569 T1 AT E340569T1 AT 03739394 T AT03739394 T AT 03739394T AT 03739394 T AT03739394 T AT 03739394T AT E340569 T1 ATE340569 T1 AT E340569T1
Authority
AT
Austria
Prior art keywords
new agent
prevent infections
cystine
theanine
agent
Prior art date
Application number
AT03739394T
Other languages
English (en)
Inventor
Susumu Shibahara
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Application granted granted Critical
Publication of ATE340569T1 publication Critical patent/ATE340569T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
AT03739394T 2002-02-18 2003-02-06 Verwendung eines neuen mittels zur verhütung von infektionen ATE340569T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002040845 2002-02-18

Publications (1)

Publication Number Publication Date
ATE340569T1 true ATE340569T1 (de) 2006-10-15

Family

ID=27678324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03739394T ATE340569T1 (de) 2002-02-18 2003-02-06 Verwendung eines neuen mittels zur verhütung von infektionen

Country Status (6)

Country Link
EP (1) EP1486208B1 (de)
JP (1) JP3953031B2 (de)
AT (1) ATE340569T1 (de)
AU (1) AU2003245835A1 (de)
DE (1) DE60308663T2 (de)
WO (1) WO2003068214A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005123058A1 (ja) * 2004-06-15 2008-04-10 大阪府 老化防止剤
WO2009102050A1 (ja) 2008-02-15 2009-08-20 Ajinomoto Co., Inc. 腸管免疫賦活剤
GB2470012B (en) 2009-05-05 2016-04-27 Gm Global Tech Operations Llc Variable Displacement Vane Pump
WO2015015989A1 (ja) * 2013-07-31 2015-02-05 味の素株式会社 癌化学療法時の副作用軽減剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090106A2 (de) * 1998-06-30 2001-04-11 The Brigham And Women's Hospital, Inc. Alkylamine und ihre verläufer als spezifische modulatoren der menschlichen gamma-delta t-zellfunktion.
JP3988014B2 (ja) * 2000-02-02 2007-10-10 味の素株式会社 ウイルス感染症予防剤
WO2002089786A1 (en) * 2001-04-24 2002-11-14 Taiyo Kagaku Co., Ltd. Compositions for improving mental concentration

Also Published As

Publication number Publication date
DE60308663D1 (de) 2006-11-09
JP3953031B2 (ja) 2007-08-01
AU2003245835A1 (en) 2003-09-04
EP1486208A4 (de) 2005-06-01
EP1486208A1 (de) 2004-12-15
JPWO2003068214A1 (ja) 2005-06-02
WO2003068214A1 (en) 2003-08-21
EP1486208B1 (de) 2006-09-27
DE60308663T2 (de) 2007-08-09

Similar Documents

Publication Publication Date Title
DE60332163D1 (de) Zusammensetzung zur hautaufhellung
BR0317715A (pt) Composições e processos de uso de collajolie
ATE368031T1 (de) Neue gamma secretase inhibitoren
CY1111050T1 (el) Φωσφονικα, μονοφωσφοναμιδικα, διφωσφοναμιδικα για την αγωγη των ιϊκων παθησεων
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
AP2003002915A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
CY1110835T1 (el) Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c
CY1106958T1 (el) Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
DK1754475T3 (da) Anvendelse af C-terminal modificerede oxamyl dipeptider som inhibitorer af ice/ced-3 familien af cysteinproteaser
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE602005020056D1 (de) Verstärker von glutamat-rezeptoren
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
PT1289366E (pt) Combinacoes fungicidas de substancias activas
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
DK1558580T3 (da) N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridoner
DE60308663D1 (de) Verwendung eines neuen mittels zur verhütung von infektionen
ATE328898T1 (de) Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung
DK1619185T3 (da) 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt deraf
DE60305279D1 (de) Verwendung von Methyltestosteron zur Behandlung von menschlichen Papillomavirus Infektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties